Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Number of Accident and Trauma Cases
4.2.2 Increasing Awareness about the Benefits Offered by Amniotic Membrane
4.2.3 Rising Research on Stem Cell Biology and Regenerative Medicine
4.3 Market Restraints
4.3.1 Lack of Standardized Guidelines
4.3.2 Lack of Skilled Professionals
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Enzyme
5.1.1 Cryopreserved Amniotic Membrane
5.1.2 Dehydrated Amniotic Membrane
5.2 By Application
5.2.1 Ophthalmology
5.2.2 Surgical Wounds
5.2.3 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Amnio Technology, LLC
6.1.2 TissueTech, Inc. (BioTissue)
6.1.3 Human Regenerative Technologies, LLC
6.1.4 Katena Products. Inc.
6.1.5 MIMEDX
6.1.6 Integra LifeSciences Corporation
6.1.7 Skye Biologics Inc.
6.1.8 Amniox Medical Inc.
6.1.9 Laboratoire CCD
6.1.10 VIVEX Biologics, Inc.
6.1.11 Merakris Therapeutics
6.1.12 Akorn Operating Company LLC


7 MARKET OPPORTUNITIES AND FUTURE TRENDS